Elutia Inc. (ELUT) stock
ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.85+0.03 (+3.77%)
Close on Nov 17, 2026Market cap $37.82MP/E –Yield –
Elutia price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Elutia's price to book ratio was 2.7× on Nov 11, 2026, against 10.7× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.7× | −8.6 |
| 2022 | Jul 29, 2022 | 11.3× | – |
See a number that looks wrong?